The growth of subcutaneous sarcomas carrying either IDH1 WT or IDH1R132H was investigated following preventative vaccination: tumours positive for IDH1R132H grew more slowly than those expressing the WT protein [205], showing the efficacy of the anti-tumour therapy. Here, IDH1 is linked to neoplasm.